Evidence map›Paper›PMID 34642370›Full record

ArticleScientific reports2021

A pilot study about the development and characterization of a Roux en Y gastric bypass model in obese Yucatan minipigs.

Damien Bergeat, S Blat, Y Gautier, S Guérin, I Le Huërou-Luron, R Thibault, D Val-Laillet

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Damien BergeatINRAE, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer (NuMeCan), Saint-Gilles, Rennes, France. damien.bergeat@chu-rennes.fr.
S BlatINRAE, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer (NuMeCan), Saint-Gilles, Rennes, France.
Y GautierINRAE, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer (NuMeCan), Saint-Gilles, Rennes, France.
S GuérinINRAE, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer (NuMeCan), Saint-Gilles, Rennes, France.
I Le Huërou-LuronINRAE, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer (NuMeCan), Saint-Gilles, Rennes, France.
R Thibault *INRAE, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer (NuMeCan), Saint-Gilles, Rennes, France.
D Val-Laillet *INRAE, INSERM, Univ Rennes, Nutrition Metabolisms and Cancer (NuMeCan), Saint-Gilles, Rennes, France.
Inserm · FRCentre Hospitalier Universitaire de Rennes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Performing the Roux-en-Y gastric bypass (RYGBP) in obese Yucatan minipigs provides an opportunity to explore the mechanisms behind the effects of this surgery in controlled environmental and nutritional conditions. We hypothesized that RYGBP in these minipigs would induce changes at multiple levels, as in obese humans. We sought to characterize RYGBP in a diet-induced obese minipig model, compared with a pair-fed sham group. After inducing obesity with an ad libitum high-fat/high-sugar diet, we performed RYGBP (n = 7) or sham surgery (n = 6). Oral glucose tolerance tests (OGTT) were performed before and after surgery. Histological analyses were conducted to compare the alimentary limb at sacrifice with tissue sampled during RYGBP surgery. One death occurred in the RYGBP group at postoperative day (POD) 3. Before sacrifice, weight loss was the same across groups. GLP-1 secretion (OGTT) was significantly higher at 15, 30 and 60 min at POD 7, and at 30 and 60 min at POD 30 in the RYGBP group. Incremental insulin area under the curve increased significantly after RYGBP (p = 0.02). RYGBP induced extensive remodeling of the alimentary limb. Results show that RYGBP can be safely performed in obese minipigs, and changes mimic those observed in humans.

Indexed as

AnimalsDiet, High-FatDisease Models, AnimalGastric BypassGlucagon-Like Peptide 1Glucose Tolerance TestHumansObesity, MorbidPilot ProjectsSwineSwine, MiniatureTreatment OutcomeGlucagon-Like Peptide 1

Identifiers

PMID34642370
PMCPMC8511153
OpenAlexW3207469164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.